Japanese Drugmaker Draws FDA Warning for Repeat Offenses

Drug Industry Daily
A A
Citing data integrity concerns, the FDA hit Kyowa Hakka Bio with another warning letter for repeat violations at its Hofu, Yamaguchi facility. The agency issued a previous warning to the facility in 2010.

To View This Article:

Login

Subscribe To Drug Industry Daily